Pelotonia Institute for Immuno-Oncology

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

June, 2025

Pelotonia Institute for Immuno-Oncology

Jun 23, 2025, 11:18 | Insight

Zihai Li: Are NK Cells Friends or Foes In Cancer Immunotherapy?

Zihai Li, Professor and Founding Director at the Pelotonia Institute for Immuno-Oncology, shared a post…

Apr 13, 2025, 14:44 | Blog

First-in-Human PIIO-1 Trial for Recurrent Glioblastoma Receives IND Approval - Pelotonia Institute for Immuno-Oncology

Pelotonia Institute for Immuno-Oncology shared a post on X: "We’re celebrating IND approval for the first…

Dec 18, 2024, 13:17 | Blog

Registration for TRCCC 2025 is Now Open

Pelotonia Institute for Immuno-Oncology posted on X: "Registration for TRCCC 2025 is NOW OPEN! 7…

All: 3 Posts: 1 - 100

'

BEATcc Trial at ESMOGynaec25: Atezolizumab Benefits Cervical Cancer Patients Regardless of PD-L1 Status

'

15 Posts Not to Miss from EACR 2025

'

ASCO 2025 RCC Advances: Expert Insights by Ilya Tsimafeyeu

'

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine

'

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023